Counternarcotics Strategy for the Western Hemisphere

Counternarcotics Strategy for the Western Hemisphere
Author: United States. Congress. House. Committe
Publisher: Hardpress Publishing
Total Pages: 200
Release: 2013-12
Genre:
ISBN: 9781314866926

Unlike some other reproductions of classic texts (1) We have not used OCR(Optical Character Recognition), as this leads to bad quality books with introduced typos. (2) In books where there are images such as portraits, maps, sketches etc We have endeavoured to keep the quality of these images, so they represent accurately the original artefact. Although occasionally there may be certain imperfections with these old texts, we feel they deserve to be made available for future generations to enjoy.

Counternarcotics, Overview of U.S. Efforts in the Western Hemisphere

Counternarcotics, Overview of U.S. Efforts in the Western Hemisphere
Author: United States. Government Accountability Office
Publisher:
Total Pages: 62
Release: 2017
Genre: Drug control
ISBN:

Western Hemisphere nations such as Mexico and Colombia are major sources of illicit drugs such as cocaine, heroin, methamphetamine, and marijuana. Precursor chemicals used in the production of illicit fentanyl and other dangerous synthetic drugs often originate in China but typically enter the United States through Canada and Mexico. U.S. agencies implementing the National Drug Control Strategy conduct several activities to disrupt the flow of illicit drugs and dismantle the organizations that control them (see fig.). In December 2016, Congress established the Western Hemisphere Drug Policy Commission to, among other things, evaluate the U.S.-funded counternarcotics programs in the Western Hemisphere. In this context, GAO was asked to review key issues related to U.S. counternarcotics efforts in the Western Hemisphere. This report examines (1) U.S. agencies’ spending for counternarcotic efforts in the Western Hemisphere during fiscal years 2010- 2015, the most recent data available; (2) how agencies are gathering and sharing best practices and lessons learned from their counternarcotics efforts domestically and internationally; and (3) mechanisms U.S. agencies have used to address changing drug threats. GAO is not making any recommendations in this report.